🔎 Trials Near Me

Gara Jalqabaatti › Glioma › Distaarikii Koloombiyaa

Qorannoo klinikaalii Glioma Distaarikii Koloombiyaa keessatti

Qorannoo 14 Glioma f Distaarikii Koloombiyaa keessatti hirmaatuu jiru.

Magaalota Distaarikii Koloombiyaa keessatti

Takkalaa qorannoo (Ingiliffa)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 21 Years · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07326566

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
12 Months – 39 Years · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06838676

NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors

  • Children's National Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 3 hanga 25 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07664176

Targeted Pediatric High-Grade Glioma Therapy

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraQorannoo ilaalaa
12 Months – 39 Years · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 hanga 39 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 3 hanga 39 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05096481

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 25 · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT04485559

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

  • Children's National Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 1 hanga 26 · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT06712875

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa jalqabaa 1Hojjettoota fayyaa simatamoo
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT06333899

A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

  • Children's National Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 4 fi ol · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT04573140

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
12 Months – 39 Years · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Sibley Memorial Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Hanga umuriin 21 · Saalaa hunda · Haaromfame 18-Bit-2026 · NCT04655404

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.